NIH clinical trial tests Remdesivir plus anti-inflammatory drug Baricitinib for COVID-19
Credit: NIAID A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug...
















